Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection
- 1 June 2014
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 184, 51-57
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside AnaloguesHIV Research & Clinical Practice, 2013
- PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitroJournal of Controlled Release, 2012
- Expanding access to HAART: a cost-effective approach for treating and preventing HIVAIDS, 2010
- Gene Therapy in HIV‐Infected Cells to Decrease Viral Impact by Using an Alternative Delivery MethodChemMedChem, 2010
- Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytesJournal of Controlled Release, 2008
- Genetic therapies against HIVNature Biotechnology, 2007
- siRNA Delivery into Human T Cells and Primary Cells with Carbon‐Nanotube TransportersAngewandte Chemie International Edition, 2007
- Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: Chemistry and cell deliveryBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Clinical perspective of fusion inhibitors for treatment of HIVJournal of Antimicrobial Chemotherapy, 2004
- The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotidesBiomaterials, 2002